JULIE KRAEGER: Open Payments
NPI 1639664477 · LOWVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 26 payments from 9 companies in 2025. Trend: 2023 $223 · 2024 $430 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $174 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| Lilly USA, LLC | 3 | $63 |
| Novo Nordisk Inc | 2 | $46 |
| Dexcom, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: VRAYLAR, AIRSUPRA, Wegovy, JARDIANCE, Dexcom G6 Transmitter, XIFAXAN, UBRELVY, REXULTI.
Industry payments across NY — which companies pay providers there.
